2025 American Society of Clinical Oncology (ASCO) Annual Meeting Poster Presentation: ST-001 nanoFenretinide™ Trial in Patients with T-cell Non-Hodgkin Lymphoma

NEWS PROVIDED BY
SciTech Development
05 Jun, 2025, 09:00 ET

CHICAGO, Jun. 5, 2025 — SciTech Development presented a poster at the June 2025 American Society of Clinical Oncology (ASCO) meeting in Chicago, showcasing the ST-001 nanoFenretinide^™ trial in patients with T-cell Non-Hodgkin Lymphoma.

About SciTech Development, Inc.

SciTech Development, Inc. is a clinical-stage biotechnology company dedicated to the development of novel therapies for the treatment of cancer. SciTech is focused on advancing its clinical programs to bring innovative and effective cancer treatments to patients worldwide.

For more information about SciTech Development and its clinical programs, please visit www.SciTechSDP.com.

This press release may contain forward-looking statements that are subject to risks and uncertainties. These statements are based on current expectations and assumptions and are not guarantees of future performance.

CONTACT

SciTech Development: Investor Relations
David Schaffer
DRS@SciTechDevelopment.com